Article
Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
20 Mar 2023
Abstract excerpt
Colon cancer is the fourth leading cause of cancer death worldwide, and its progression is accompanied by a complex array of genetic variations. CRISPR/Cas9 can identify new drug-resistant or sensitive mutations in colon cancer, and can use gene editing technology to develop new therapeutic targets and provide personalized treatments, thereby significantly improving the treatment of colon cancer patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
